Sfoglia per Autore
Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence
2025-01-01 Manfredi, Giulia Francesca; Fulgenzi, Claudia Angela Maria; Celsa, Ciro; Stefanini, Bernardo; D'Alessio, Antonio; Pinter, Matthias; Scheiner, Bernhard; Awosika, Nichola; Brunetti, Leonardo; Lombardi, Pasquale; Latchford, Charles; Lee, Pei-Chang; Huang, Yi-Hsiang; Lin, Chun-Yen; Dalbeni, Andrea; Vogel, Arndt; Galle, Peter R.; Kudo, Masatoshi; Rimassa, Lorenza; Chon, Hong Jae; Cabibbo, Giuseppe; Piscaglia, Fabio; Cammà, Calogero; Pillai, Anjana; Pirisi, Mario; Singal, Amit G.; Pinato, David J.
Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study
2025-01-01 Lombardi, Pasquale; Kim, Jung Sun; Manfredi, Giulia F.; Celsa, Ciro; Fulgenzi, Claudia A. M.; D'Alessio, Antonio; Stefanini, Bernardo; Doshi, Niraj C.; Warmington, Emily; Marron, Thomas U.; Pinter, Matthias; Scheiner, Bernhard; Kang, Beodeul; Lim, Ho Yeong; Hsu, Wei-Fan; Wietharn, Brooke; Silletta, Marianna; Parisi, Alessandro; Lin, Chun-Yen; Dalbeni, Andrea; Masi, Gianluca; Schönlein, Martin; Von Felden, Johann; Piscaglia, Fabio; Galle, Peter R.; Kudo, Masatoshi; Pressiani, Tiziana; Rimassa, Lorenza; Pirisi, Mario; Cabibbo, Giuseppe; Chon, Hong Jae; Pinato, David J.
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis
2025-01-01 Celsa, Ciro; Di Maria, Gabriele; Lombardi, Pasquale; D'Alessio, Antonio; Fulgenzi, Claudia A M; Brunetti, Leonardo; Manfredi, Giulia F; Stefanini, Bernardo; Sparacino, Alba; Rigamonti, Cristina; Pirisi, Mario; Latchford, Charles; Vaccaro, Marco; Enea, Marco; Cammà, Calogero; Cabibbo, Giuseppe; Pinato, David James
Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trial
2025-01-01 Takada, K.; Takamori, S.; Shimokawa, M.; Pinato, D. J.; Cortellini, A.
ctDNA: A Gateway for Personalized Risk Stratification in Surgically Resectable Hepatocellular Cancer
2025-01-01 Pinato, David J; Lombardi, Pasquale; D'Alessio, Antonio; Torkpour, Aria; Fulgenzi, Claudia Angela Maria; Brunetti, Leonardo
Reply: Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment
2024-01-01 Celsa, Ciro; Cabibbo, Giuseppe; Pinato, David James
Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapy-based systemic therapy
2024-01-01 Scheiner, B.; Kang, B.; Balcar, L.; Radu, I. -P.; Reiter, F. P.; Adzic, G.; Guo, J.; Gao, X.; Yuan, X.; Cheng, L.; Gorgulho, J.; Schultheiss, M.; Peeters, F.; Hucke, F.; Ben Khaled, N.; Piseddu, I.; Philipp, A.; Sinner, F.; D'Alessio, A.; Pomej, K.; Saborowski, A.; Bathon, M.; Schwacha-Eipper, B.; Zarka, V.; Lampichler, K.; Nishida, N.; Lee, P. -C.; Krall, A.; Saeed, A.; Himmelsbach, V.; Tesini, G.; Huang, Y. -H.; Vivaldi, C.; Masi, G.; Vogel, A.; Schulze, K.; Trauner, M.; Djanani, A.; Stauber, R.; Kudo, M.; Parikh, N. D.; Dufour, J. -F.; Prejac, J.; Geier, A.; Bengsch, B.; von Felden, J.; Venerito, M.; Weinmann, A.; Peck-Radosavljevic, M.; Finkelmeier, F.; Dekervel, J.; Ji, F.; Wang, H. -W.; Rimassa, L.; Pinato, D. J.; Bouattour, M.; Chon, H. J.; Pinter, M.
Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: A systematic review
2024-01-01 Galle, P.; Finn, R. S.; Mitchell, C. R.; Ndirangu, K.; Ramji, Z.; Redhead, G. S.; Pinato, D. J.
Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram
2024-01-01 Losurdo, A.; Dipasquale, A.; Giordano, L.; Persico, P.; Lorenzi, E.; Di Muzio, A.; Barigazzi, C.; Korolewicz, J.; Mehan, A.; Mohammed, O.; Scheiner, B.; Pinato, D. J.; Santoro, A.; Simonelli, M.
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry
2024-01-01 Vincenzi, Bruno; Cortellini, Alessio; Mazzocca, Alessandro; Orlando, Sarah; Romandini, Davide; Aguilar-Company, Juan; Ruiz-Camps, Isabel; Valverde Morales, Claudia; Eremiev-Eremiev, Simeon; Tondini, Carlo; Brunet, Joan; Bertulli, Rossella; Provenzano, Salvatore; Bower, Mark; Generali, Daniele; Salazar, Ramon; Sureda, Anna; Prat, Aleix; Vasiliki, Michalarea; Van Hemelrijck, Mieke; Sita-Lumsden, Ailsa; Bertuzzi, Alexia; Rossi, Sabrina; Jackson, Amanda; Grosso, Federica; Lee, Alvin J. X.; Murphy, Cian; Belessiotis, Katherine; Mukherjee, Uma; Pommeret, Fanny; Loizidou, Angela; Gaidano, Gianluca; Dettorre, Gino M.; Grisanti, Salvatore; Tucci, Marco; Fulgenzi, Claudia A. M.; Gennari, Alessandra; Napolitano, Andrea; Pinato, David J.
Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison
2024-01-01 Agirrezabal, I.; Bouattour, M.; Pinato, D. J.; D'Alessio, A.; Brennan, V. K.; Carion, P. L.; Shergill, S.; Amoury, N.; Vilgrain, V.
Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future
2024-01-01 Singal, A. G.; Yarchoan, M.; Yopp, A.; Sapisochin, G.; Pinato, D. J.; Pillai, A.
Beyond Time and Space: Charting Dynamic Evolution of Sporadic Colorectal Cancer
2024-01-01 Lombardi, P.; Pinato, D. J.
Immunotherapy at all stages of hepatocellular carcinoma
2024-01-01 Pinato, D. J.; Fulgenzi, C. A. M.; D'Alessio, A.
Inflammation as a Pathogenic Mechanism of Colonic Neoplasia in Primary Sclerosing Cholangitis
2024-01-01 Manfredi, G. F.; Pinato, D. J.
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024-01-01 Hedayat, S.; Cascione, L.; Cunningham, D.; Schirripa, M.; Lampis, A.; Hahne, J. C.; Tunariu, N.; Hong, S. P.; Marchetti, S.; Khan, K.; Fontana, E.; Angerilli, V.; Delrieux, M.; Rodrigues, D. N.; Procaccio, L.; Rao, S.; Watkins, D.; Starling, N.; Chau, I.; Braconi, C.; Fotiadis, N.; Begum, R.; Guppy, N.; Howell, L.; Valenti, M.; Cribbes, S.; Kolozsvari, B.; Kirkin, V.; Lonardi, S.; Ghidini, M.; Passalacqua, R.; Elghadi, R.; Magnani, L.; Pinato, D. J.; Di Maggio, F.; Ghelardi, F.; Sottotetti, E.; Vetere, G.; Ciraci, P.; Vlachogiannis, G.; Pietrantonio, F.; Cremolini, C.; Cortellini, A.; Loupakis, F.; Fassan, M.; Valeri, N.
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry
2024-01-01 Mostaghim, Anahita; Minkove, Samuel; Aguilar-Company, Juan; Ruiz-Camps, Isabel; Eremiev-Eremiev, Simeon; Dettorre, Gino M.; Fox, Laura; Tondini, Carlo; Brunet, Joan; Carmona-García, Mcarmen; Lambertini, Matteo; Bower, Mark; Newsom-Davis, Thomas; Sharkey, Rachel; Dalla Pria, Alessia; Rossi, Maura; Plaja, Andrea; Salazar, Ramon; Sureda, Anna; Prat, Aleix; Michalarea, Vasiliki; Van Hemelrijck, Mieke; Sita-Lumsden, Ailsa; Bertuzzi, Alexia; Rimassa, Lorenza; Rossi, Sabrina; Paolo Pedrazzoli, Gianpiero Rizzo.; JX Lee, Alvin; Murphy, Cian; Belessiotis, Katherine; Diamantis, Nikolaos; Mukherjee, Uma; Pommeret, Fanny; Stoclin, Annabelle; Martinez-Vila, Clara; Bruna, Riccardo; Gaidano, Gianluca; D'Avanzo, Francesca; Gennari, Alessandra; Athale, Janhavi; Eichacker, Peter; Pinato, David J.; Torabi-Parizi, Parizad; Cortellini, Alessio
Deep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer
2024-01-01 Rakaee, Mehrdad; Tafavvoghi, Masoud; Ricciuti, Biagio; Alessi, Joao V; Cortellini, Alessio; Citarella, Fabrizio; Nibid, Lorenzo; Perrone, Giuseppe; Adib, Elio; Fulgenzi, Claudia A M; Murilo Hidalgo Filho, Cassio; Di Federico, Alessandro; Jabar, Falah; Hashemi, Sayed; Houda, Ilias; Richardsen, Elin; Rasmussen Busund, Lill-Tove; Donnem, Tom; Bahce, Idris; Pinato, David J; Helland, Åslaug; Sholl, Lynette M; Awad, Mark M; Kwiatkowski, David J
Immunotherapy Benefit Over Best Supportive Care in Hepatocellular Cancer With Child-Pugh B Dysfunction-Reply
2024-01-01 Fulgenzi, Claudia A M; D'Alessio, Antonio; Pinato, David J
Early hepatic decompensation identifies patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab or Sorafenib at highest risk of death
2024-01-01 Cabibbo, Giuseppe; Celsa, Ciro; Battaglia, Salvatore; Enea, Marco; Di Maria, Gabriele; Grova, Alessandro; Ciccia, Roberta; Manfredi, Giulia F; Iavarone, Massimo; Vogel, Arndt; Singal, Amit G; Reig, Maria; Pinato, David J; Cammà, Calogero
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence | 1-gen-2025 | Manfredi, Giulia Francesca; Fulgenzi, Claudia Angela Maria; Celsa, Ciro; Stefanini, Bernardo; D'Alessio, Antonio; Pinter, Matthias; Scheiner, Bernhard; Awosika, Nichola; Brunetti, Leonardo; Lombardi, Pasquale; Latchford, Charles; Lee, Pei-Chang; Huang, Yi-Hsiang; Lin, Chun-Yen; Dalbeni, Andrea; Vogel, Arndt; Galle, Peter R.; Kudo, Masatoshi; Rimassa, Lorenza; Chon, Hong Jae; Cabibbo, Giuseppe; Piscaglia, Fabio; Cammà, Calogero; Pillai, Anjana; Pirisi, Mario; Singal, Amit G.; Pinato, David J. | |
| Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study | 1-gen-2025 | Lombardi, Pasquale; Kim, Jung Sun; Manfredi, Giulia F.; Celsa, Ciro; Fulgenzi, Claudia A. M.; D'Alessio, Antonio; Stefanini, Bernardo; Doshi, Niraj C.; Warmington, Emily; Marron, Thomas U.; Pinter, Matthias; Scheiner, Bernhard; Kang, Beodeul; Lim, Ho Yeong; Hsu, Wei-Fan; Wietharn, Brooke; Silletta, Marianna; Parisi, Alessandro; Lin, Chun-Yen; Dalbeni, Andrea; Masi, Gianluca; Schönlein, Martin; Von Felden, Johann; Piscaglia, Fabio; Galle, Peter R.; Kudo, Masatoshi; Pressiani, Tiziana; Rimassa, Lorenza; Pirisi, Mario; Cabibbo, Giuseppe; Chon, Hong Jae; Pinato, David J. | |
| Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis | 1-gen-2025 | Celsa, Ciro; Di Maria, Gabriele; Lombardi, Pasquale; D'Alessio, Antonio; Fulgenzi, Claudia A M; Brunetti, Leonardo; Manfredi, Giulia F; Stefanini, Bernardo; Sparacino, Alba; Rigamonti, Cristina; Pirisi, Mario; Latchford, Charles; Vaccaro, Marco; Enea, Marco; Cammà, Calogero; Cabibbo, Giuseppe; Pinato, David James | |
| Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trial | 1-gen-2025 | Takada, K.; Takamori, S.; Shimokawa, M.; Pinato, D. J.; Cortellini, A. | |
| ctDNA: A Gateway for Personalized Risk Stratification in Surgically Resectable Hepatocellular Cancer | 1-gen-2025 | Pinato, David J; Lombardi, Pasquale; D'Alessio, Antonio; Torkpour, Aria; Fulgenzi, Claudia Angela Maria; Brunetti, Leonardo | |
| Reply: Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment | 1-gen-2024 | Celsa, Ciro; Cabibbo, Giuseppe; Pinato, David James | |
| Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapy-based systemic therapy | 1-gen-2024 | Scheiner, B.; Kang, B.; Balcar, L.; Radu, I. -P.; Reiter, F. P.; Adzic, G.; Guo, J.; Gao, X.; Yuan, X.; Cheng, L.; Gorgulho, J.; Schultheiss, M.; Peeters, F.; Hucke, F.; Ben Khaled, N.; Piseddu, I.; Philipp, A.; Sinner, F.; D'Alessio, A.; Pomej, K.; Saborowski, A.; Bathon, M.; Schwacha-Eipper, B.; Zarka, V.; Lampichler, K.; Nishida, N.; Lee, P. -C.; Krall, A.; Saeed, A.; Himmelsbach, V.; Tesini, G.; Huang, Y. -H.; Vivaldi, C.; Masi, G.; Vogel, A.; Schulze, K.; Trauner, M.; Djanani, A.; Stauber, R.; Kudo, M.; Parikh, N. D.; Dufour, J. -F.; Prejac, J.; Geier, A.; Bengsch, B.; von Felden, J.; Venerito, M.; Weinmann, A.; Peck-Radosavljevic, M.; Finkelmeier, F.; Dekervel, J.; Ji, F.; Wang, H. -W.; Rimassa, L.; Pinato, D. J.; Bouattour, M.; Chon, H. J.; Pinter, M. | |
| Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: A systematic review | 1-gen-2024 | Galle, P.; Finn, R. S.; Mitchell, C. R.; Ndirangu, K.; Ramji, Z.; Redhead, G. S.; Pinato, D. J. | |
| Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram | 1-gen-2024 | Losurdo, A.; Dipasquale, A.; Giordano, L.; Persico, P.; Lorenzi, E.; Di Muzio, A.; Barigazzi, C.; Korolewicz, J.; Mehan, A.; Mohammed, O.; Scheiner, B.; Pinato, D. J.; Santoro, A.; Simonelli, M. | |
| Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry | 1-gen-2024 | Vincenzi, Bruno; Cortellini, Alessio; Mazzocca, Alessandro; Orlando, Sarah; Romandini, Davide; Aguilar-Company, Juan; Ruiz-Camps, Isabel; Valverde Morales, Claudia; Eremiev-Eremiev, Simeon; Tondini, Carlo; Brunet, Joan; Bertulli, Rossella; Provenzano, Salvatore; Bower, Mark; Generali, Daniele; Salazar, Ramon; Sureda, Anna; Prat, Aleix; Vasiliki, Michalarea; Van Hemelrijck, Mieke; Sita-Lumsden, Ailsa; Bertuzzi, Alexia; Rossi, Sabrina; Jackson, Amanda; Grosso, Federica; Lee, Alvin J. X.; Murphy, Cian; Belessiotis, Katherine; Mukherjee, Uma; Pommeret, Fanny; Loizidou, Angela; Gaidano, Gianluca; Dettorre, Gino M.; Grisanti, Salvatore; Tucci, Marco; Fulgenzi, Claudia A. M.; Gennari, Alessandra; Napolitano, Andrea; Pinato, David J. | |
| Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison | 1-gen-2024 | Agirrezabal, I.; Bouattour, M.; Pinato, D. J.; D'Alessio, A.; Brennan, V. K.; Carion, P. L.; Shergill, S.; Amoury, N.; Vilgrain, V. | |
| Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future | 1-gen-2024 | Singal, A. G.; Yarchoan, M.; Yopp, A.; Sapisochin, G.; Pinato, D. J.; Pillai, A. | |
| Beyond Time and Space: Charting Dynamic Evolution of Sporadic Colorectal Cancer | 1-gen-2024 | Lombardi, P.; Pinato, D. J. | |
| Immunotherapy at all stages of hepatocellular carcinoma | 1-gen-2024 | Pinato, D. J.; Fulgenzi, C. A. M.; D'Alessio, A. | |
| Inflammation as a Pathogenic Mechanism of Colonic Neoplasia in Primary Sclerosing Cholangitis | 1-gen-2024 | Manfredi, G. F.; Pinato, D. J. | |
| Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer | 1-gen-2024 | Hedayat, S.; Cascione, L.; Cunningham, D.; Schirripa, M.; Lampis, A.; Hahne, J. C.; Tunariu, N.; Hong, S. P.; Marchetti, S.; Khan, K.; Fontana, E.; Angerilli, V.; Delrieux, M.; Rodrigues, D. N.; Procaccio, L.; Rao, S.; Watkins, D.; Starling, N.; Chau, I.; Braconi, C.; Fotiadis, N.; Begum, R.; Guppy, N.; Howell, L.; Valenti, M.; Cribbes, S.; Kolozsvari, B.; Kirkin, V.; Lonardi, S.; Ghidini, M.; Passalacqua, R.; Elghadi, R.; Magnani, L.; Pinato, D. J.; Di Maggio, F.; Ghelardi, F.; Sottotetti, E.; Vetere, G.; Ciraci, P.; Vlachogiannis, G.; Pietrantonio, F.; Cremolini, C.; Cortellini, A.; Loupakis, F.; Fassan, M.; Valeri, N. | |
| Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry | 1-gen-2024 | Mostaghim, Anahita; Minkove, Samuel; Aguilar-Company, Juan; Ruiz-Camps, Isabel; Eremiev-Eremiev, Simeon; Dettorre, Gino M.; Fox, Laura; Tondini, Carlo; Brunet, Joan; Carmona-García, Mcarmen; Lambertini, Matteo; Bower, Mark; Newsom-Davis, Thomas; Sharkey, Rachel; Dalla Pria, Alessia; Rossi, Maura; Plaja, Andrea; Salazar, Ramon; Sureda, Anna; Prat, Aleix; Michalarea, Vasiliki; Van Hemelrijck, Mieke; Sita-Lumsden, Ailsa; Bertuzzi, Alexia; Rimassa, Lorenza; Rossi, Sabrina; Paolo Pedrazzoli, Gianpiero Rizzo.; JX Lee, Alvin; Murphy, Cian; Belessiotis, Katherine; Diamantis, Nikolaos; Mukherjee, Uma; Pommeret, Fanny; Stoclin, Annabelle; Martinez-Vila, Clara; Bruna, Riccardo; Gaidano, Gianluca; D'Avanzo, Francesca; Gennari, Alessandra; Athale, Janhavi; Eichacker, Peter; Pinato, David J.; Torabi-Parizi, Parizad; Cortellini, Alessio | |
| Deep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer | 1-gen-2024 | Rakaee, Mehrdad; Tafavvoghi, Masoud; Ricciuti, Biagio; Alessi, Joao V; Cortellini, Alessio; Citarella, Fabrizio; Nibid, Lorenzo; Perrone, Giuseppe; Adib, Elio; Fulgenzi, Claudia A M; Murilo Hidalgo Filho, Cassio; Di Federico, Alessandro; Jabar, Falah; Hashemi, Sayed; Houda, Ilias; Richardsen, Elin; Rasmussen Busund, Lill-Tove; Donnem, Tom; Bahce, Idris; Pinato, David J; Helland, Åslaug; Sholl, Lynette M; Awad, Mark M; Kwiatkowski, David J | |
| Immunotherapy Benefit Over Best Supportive Care in Hepatocellular Cancer With Child-Pugh B Dysfunction-Reply | 1-gen-2024 | Fulgenzi, Claudia A M; D'Alessio, Antonio; Pinato, David J | |
| Early hepatic decompensation identifies patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab or Sorafenib at highest risk of death | 1-gen-2024 | Cabibbo, Giuseppe; Celsa, Ciro; Battaglia, Salvatore; Enea, Marco; Di Maria, Gabriele; Grova, Alessandro; Ciccia, Roberta; Manfredi, Giulia F; Iavarone, Massimo; Vogel, Arndt; Singal, Amit G; Reig, Maria; Pinato, David J; Cammà, Calogero |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile